THI21 Antibody

What is THI2.1 Antibody and what is its target antigen?

THI2.1 Antibody is a rabbit polyclonal antibody developed against the THI2.1 antigen, which is associated with Viscotoxin-A3 found in Viscum album (European mistletoe) . The antibody recognizes the protein with Gene ID P01538, which has synonyms including "Acidic protein" and "Viscotoxin-A3" . The target antigen corresponds to a protein fragment in the 27-72 amino acid range with the sequence K S C C P N T T G R N I Y N A C R L T G A P R P T C A K L S G C K I I S G S T C P S D Y P K . This protein is related to the constant region of immunoglobulin light chains, which are components of antibodies produced by B lymphocytes .

What are the common applications of THI2.1 Antibody in laboratory research?

The THI2.1 antibody has been validated for several critical research applications:

• ELISA (Enzyme-Linked Immunosorbent Assay): The antibody has been confirmed effective for detecting THI2.1 protein in solution-based immunoassays .

• Western Blot: THI2.1 antibody can be used to detect its target protein in denatured protein samples separated by electrophoresis .

The recombinant THI2.1 protein, which would be the target of the antibody, has >90% purity and is suitable for SDS-PAGE analysis , suggesting that the antibody should perform well in applications requiring detection of the denatured protein.

What are the optimal storage conditions for maintaining THI2.1 Antibody activity?

For optimal preservation of THI2.1 antibody activity, the following storage conditions are recommended:

• Storage Buffer: 0.03% Proclin 300, 50% glycerol, 0.01 M PBS, pH 7.4

• Temperature: Upon receipt, store at –20°C or –80°C

• Stability Considerations: Avoid repeated freeze-thaw cycles as these can degrade antibody performance

• Shipping: The antibody is shipped on blue ice, indicating the importance of maintaining cold chain during transport

These storage recommendations are designed to maintain the structural integrity and binding capacity of the antibody over extended periods.

How does the production method affect THI2.1 Antibody functionality?

The THI2.1 antibody is produced as a polyclonal antibody in rabbits , which has several implications for its research applications:

• Epitope Recognition: As a polyclonal antibody, it recognizes multiple epitopes on the THI2.1 antigen, potentially providing more robust detection across different experimental conditions compared to monoclonal alternatives.

• Purification Method: The antibody undergoes Protein G purification to achieve >95% purity , which removes potential contaminants that could interfere with experimental results.

• Immunogen Design: The antibody is raised against recombinant Viscum album Viscotoxin-A3 protein (specifically amino acids 27-72) , which determines its specificity for the target protein.

How should I validate the specificity of THI2.1 Antibody in my experiments?

To validate THI2.1 antibody specificity for your specific experimental system, implement the following methodological approach:

• Positive Controls: Include recombinant THI2.1 protein (aa 27-72) as a positive control . This protein has >90% purity and is suitable for SDS-PAGE, making it an ideal validation standard.

• Negative Controls: Test the antibody against samples known not to express THI2.1/Viscotoxin-A3, such as non-plant tissues or species distant from Viscum album.

• Competitive Binding Assay: Pre-incubate the antibody with purified THI2.1 protein before application to your samples. This should significantly reduce or eliminate specific binding signals.

• Western Blot Validation: Confirm that the antibody detects a protein of the expected molecular weight. The antibody should recognize a protein related to the target sequence in the 27-72 aa range .

• Cross-Reactivity Testing: If working with related species, test the antibody against samples from these species to assess potential cross-reactivity, particularly if your research involves comparative studies.

What controls should be included when using THI2.1 Antibody in Western blot assays?

For robust Western blot experiments using THI2.1 antibody, incorporate these essential controls:

Essential Controls:

• Positive Control: Include purified recombinant THI2.1 protein or extracts from Viscum album known to express the target .

• Negative Control: Process samples from tissues or organisms known not to express THI2.1/Viscotoxin-A3.

• Loading Control: Include detection of a housekeeping protein (e.g., β-actin, GAPDH) to normalize for variations in total protein loading.

• Primary Antibody Omission: Process one membrane section without primary antibody to identify non-specific binding of the secondary antibody.

• Secondary Antibody Control: Include a lane probed only with secondary antibody to detect any non-specific binding.

• Molecular Weight Marker: Include a protein ladder to verify that the detected band appears at the expected molecular weight.

These controls will help distinguish specific signal from background and validate the reliability of your Western blot results.

What are the key considerations for optimizing THI2.1 Antibody in immunohistochemistry?

While specific immunohistochemistry protocols for THI2.1 antibody are not directly provided in the search results, the following methodological approach can be applied based on fundamental immunohistochemistry principles and the known properties of THI2.1 antibody:

Optimization Protocol:

• Tissue Preparation: For plant tissues (such as Viscum album), proper fixation is critical. Consider using 4% paraformaldehyde or another aldehyde-based fixative suitable for preserving protein epitopes.

• Antigen Retrieval: Test different antigen retrieval methods (heat-induced, enzymatic) to expose the THI2.1 epitope, which may be masked during fixation.

• Antibody Dilution Series: Test a range of antibody concentrations (typically starting from 1:100 to 1:1000) to determine the optimal dilution that maximizes specific signal while minimizing background.

• Incubation Conditions: Compare different incubation times (2 hours at room temperature vs. overnight at 4°C) and buffer compositions to optimize binding conditions.

• Detection System Selection: Choose between fluorescent (similar to the approaches described in search result ) or chromogenic detection systems based on your experimental needs and available equipment.

• Counterstaining: Select appropriate counterstains that won't interfere with THI2.1 signal visualization.

Systematic optimization of these parameters will help establish a reliable immunohistochemistry protocol for THI2.1 antibody.

How can I troubleshoot non-specific binding of THI2.1 Antibody?

When encountering non-specific binding with THI2.1 antibody, implement this systematic troubleshooting approach:

Troubleshooting Protocol:

• Increase Blocking Stringency: Test different blocking agents (BSA, normal serum, commercial blockers) at various concentrations (3-5%) and longer blocking times (1-2 hours).

• Optimize Antibody Dilution: Further dilute the antibody if background is high; the optimal working dilution may need to be determined empirically for each application.

• Reduce Primary Antibody Incubation Time: Shorten incubation from overnight to 2-4 hours at room temperature to reduce non-specific binding.

• Increase Wash Stringency: Add detergent (0.1-0.3% Triton X-100 or Tween-20) to wash buffers and increase washing duration and frequency.

• Pre-adsorption: Pre-incubate the THI2.1 antibody with excess non-specific proteins (e.g., BSA) before application to your samples.

• Buffer Optimization: Adjust salt concentration in wash and incubation buffers to modify binding stringency.

• Secondary Antibody Selection: Ensure you're using a highly cross-adsorbed secondary antibody specific to rabbit IgG to minimize cross-reactivity.

These methodological approaches should help reduce non-specific binding and improve signal-to-noise ratio in your experiments.

What is known about the cross-reactivity profile of THI2.1 Antibody?

The cross-reactivity profile of THI2.1 antibody requires careful consideration for experimental design:

• Confirmed Reactivity: The antibody has been specifically validated for reactivity with Viscum album (European mistletoe) , which contains the Viscotoxin-A3 protein (THI2.1 antigen).

• Potential Cross-Reactivity Considerations:

  • The antibody targets a protein with immunoglobulin-like domains , which may share structural similarities with immunoglobulins from other species.

  • The sequence recognized by the antibody (K S C C P N T T G R N I Y N A C R L T G A P R P T C A K L S G C K I I S G S T C P S D Y P K) should be analyzed using sequence alignment tools to identify potential cross-reactive proteins in your experimental system.

• Pre-experimental Validation: Researchers should perform preliminary Western blots or ELISAs with related and unrelated proteins to establish the specificity boundaries of the antibody before proceeding with advanced applications.

• Species Considerations: While the antibody has been raised against a Viscum album protein, potential cross-reactivity with proteins from other plant species, particularly those closely related to European mistletoe, should be experimentally determined.

Understanding these cross-reactivity parameters is essential for accurate interpretation of experimental results and for designing appropriate controls.

How does THI2.1 Antibody perform in detecting structural variants of Viscotoxin-A3?

When investigating structural variants of Viscotoxin-A3 using THI2.1 antibody, researchers should consider these methodological approaches:

These approaches will help establish the detection capabilities of THI2.1 antibody across the spectrum of Viscotoxin-A3 structural variants.

Can THI2.1 Antibody be effectively conjugated for use in advanced imaging techniques?

While the search results specifically mention an unconjugated form of THI2.1 antibody , researchers interested in using this antibody for advanced imaging should consider these methodological approaches:

Conjugation Strategy:

• Direct Labeling Options: As a purified IgG (>95% purity) , THI2.1 antibody should be amenable to standard conjugation protocols using:

  • Fluorescent dyes (Alexa Fluor, FITC, Cy dyes)

  • Quantum dots for enhanced photostability

  • Enzyme conjugates (HRP, AP) for amplified detection

• Site-Specific Conjugation Considerations:

  • Use site-specific conjugation methods that target the Fc region to minimize impact on antigen binding

  • Consider biotinylation followed by streptavidin-conjugate detection for flexible signal amplification

• Validation Protocol:

  • Compare the performance of conjugated versus unconjugated antibody plus labeled secondary

  • Assess potential changes in binding affinity or specificity after conjugation

  • Verify signal-to-noise ratio using appropriate positive and negative controls

• Super-Resolution Microscopy Applications:

  • For techniques like STORM or PALM, validate that dye conjugation density is appropriate

  • Test photobleaching characteristics of the conjugated antibody

• Multiplexing Potential:

  • Evaluate spectral compatibility with other fluorophores for multi-color imaging

  • Consider sequential labeling protocols to minimize cross-reactivity in co-localization studies

These methodological considerations will help researchers effectively adapt THI2.1 antibody for advanced imaging applications while maintaining its specificity and sensitivity.

What are the considerations for using THI2.1 Antibody in studying protein-protein interactions?

For investigating protein-protein interactions involving THI2.1/Viscotoxin-A3, consider this methodological framework:

Experimental Approach:

• Co-Immunoprecipitation (Co-IP):

  • The antibody's high purity (>95%) makes it potentially suitable for Co-IP

  • Validate whether the antibody can recognize the native conformation of THI2.1

  • Consider coupling the antibody to beads or protein A/G for efficient pull-down

  • Include appropriate controls (IgG control, lysates lacking THI2.1) to distinguish specific interactions

• Proximity Ligation Assay (PLA):

  • Combine THI2.1 antibody with antibodies against suspected interaction partners

  • Optimize antibody concentrations to minimize background while maintaining sensitivity

  • Include non-interacting protein controls to validate signal specificity

• FRET/BRET Applications:

  • If conjugating the antibody with fluorophores for resonance energy transfer, validate that conjugation doesn't disrupt binding specificity

  • Consider using Fab fragments to reduce steric hindrance that might affect interaction detection

• Cross-Linking Studies:

  • Determine compatible cross-linking agents that won't interfere with antibody recognition

  • Optimize cross-linking conditions to capture transient interactions without creating artifacts

• Surface Plasmon Resonance:

  • For in vitro interaction studies, the antibody can be immobilized on sensor chips

  • Validate binding kinetics with purified THI2.1 protein before proceeding with interaction studies

These methodological considerations will help researchers effectively apply THI2.1 antibody to protein interaction studies while minimizing artifacts and maximizing sensitivity.

How should I quantify and normalize Western blot results using THI2.1 Antibody?

For robust quantification of Western blot data using THI2.1 antibody, implement this analytical framework:

Quantification Protocol:

• Image Acquisition:

  • Capture images within the linear dynamic range of your detection system

  • Use exposure settings that avoid pixel saturation for accurate quantification

  • Include a dilution series of purified THI2.1 protein to create a standard curve

• Densitometry Analysis:

  Normalization Method	Application	Advantages	Limitations
  Housekeeping Protein	General use	Simple, widely accepted	Assumes constant expression
  Total Protein Stain	High-precision work	Accounts for loading differences	Requires additional staining step
  Recombinant Standard	Absolute quantification	Enables comparison between blots	Requires purified protein standard

• Normalization Approach:

  • Normalize THI2.1 signal to total protein (using stains like Ponceau S or SYPRO Ruby)

  • Calculate the ratio of THI2.1 signal to housekeeping protein signal

  • For time-course experiments, consider normalizing to baseline (t=0) samples

• Statistical Analysis:

  • Perform replicate experiments (minimum n=3) for statistical validity

  • Apply appropriate statistical tests based on your experimental design (t-test, ANOVA)

  • Report both normalized values and measures of variation (SD, SEM)

• Common Pitfalls to Avoid:

  • Over-exposure leading to signal saturation

  • Inconsistent transfer efficiency across the membrane

  • Variation in antibody binding due to inconsistent blocking or washing

This structured approach ensures reliable quantification of THI2.1 protein levels across experimental conditions.

What statistical methods are most appropriate for analyzing THI2.1 Antibody-based assay results?

When analyzing data generated using THI2.1 antibody, select statistical methods based on your experimental design and data characteristics:

Statistical Analysis Framework:

• For Comparative Studies:

  • Two-group comparisons: Student's t-test (parametric) or Mann-Whitney U test (non-parametric)

  • Multi-group comparisons: One-way ANOVA with appropriate post-hoc tests (Tukey, Bonferroni)

  • Repeated measures: Paired t-test or repeated measures ANOVA

• For Dose-Response Studies:

  • Regression analysis to establish relationship between THI2.1 concentration and signal

  • EC50/IC50 determination using four-parameter logistic regression

  • Area under the curve (AUC) analysis for comprehensive response quantification

• For Time-Course Experiments:

  • Repeated measures ANOVA with time as the within-subject factor

  • Mixed-effects models for incomplete data sets

  • Time-to-event analysis for threshold-crossing events

• For Method Validation:

  Parameter	Statistical Method	Purpose
  Precision	Coefficient of Variation (CV)	Measures assay reproducibility
  Accuracy	% Recovery, Bland-Altman Plot	Compares to reference method
  Linearity	Linear Regression, R²	Validates detection range
  LOD/LOQ	Signal-to-noise, Standard Deviation	Determines sensitivity limits

• Power Analysis Considerations:

  • Conduct a priori power analysis to determine required sample size

  • Consider effect size based on preliminary data or literature values

  • Account for multiple comparisons when designing experiments

How can I distinguish between true positives and artifacts when using THI2.1 Antibody?

To differentiate genuine THI2.1 signals from artifacts, implement this systematic validation approach:

Signal Validation Strategy:

• Technical Controls:

  • Run parallel samples with isotype control antibody (rabbit IgG) at the same concentration

  • Include antigen pre-absorption controls where antibody is pre-incubated with purified THI2.1 protein

  • Process samples without primary antibody to identify secondary antibody artifacts

• Biological Controls:

  • Include samples known to be positive for THI2.1/Viscotoxin-A3 (e.g., Viscum album extracts)

  • Test samples from organisms that don't express THI2.1 as negative controls

  • Consider using genetic knockdown/knockout systems if available

• Cross-Method Validation:

  • Confirm key findings using an orthogonal detection method

  • Validate Western blot results with ELISA or mass spectrometry

  • Consider using a second antibody targeting a different epitope on THI2.1

• Signal Characteristics Analysis:

  Signal Type	Typical Characteristics	Troubleshooting Approach
  True Positive	Correct molecular weight, consistent location, dose-dependent	Verify with additional controls
  Cross-Reactivity	Unexpected molecular weight, present in negative controls	Pre-adsorb antibody, increase stringency
  Non-specific Binding	Diffuse signal, inconsistent between replicates	Optimize blocking, increase antibody dilution

• Digital Image Analysis:

  • Implement intensity thresholding based on negative control signal levels

  • Use pattern recognition to distinguish specific morphological distributions from artifacts

  • Analyze signal-to-background ratios across multiple samples and experiments

This comprehensive approach will help researchers confidently identify true THI2.1 signals while minimizing false positives from technical artifacts.

What approaches are recommended for comparing results from different THI2.1 Antibody lots?

To ensure reproducibility when working with different lots of THI2.1 antibody, implement this methodological framework:

Lot Comparison Protocol:

• Initial Lot Characterization:

  • Determine optimal working dilution for each lot using dilution series

  • Evaluate signal-to-noise ratio using consistent positive and negative controls

  • Assess detection limit using serial dilutions of purified THI2.1 protein

• Side-by-Side Comparison:

  • Test both antibody lots simultaneously on identical samples

  • Include internal reference samples that will be preserved for future lot testing

  • Quantify relative sensitivity and specificity between lots

• Calibration Approach:

  Parameter	Method	Application
  Sensitivity Adjustment	Determine relative dilution factors	For semi-quantitative applications
  Standard Curve Calibration	Create lot-specific standard curves	For quantitative measurements
  Normalization Factor	Calculate inter-lot conversion factors	For comparing historical data

• Documentation and Traceability:

  • Maintain detailed records of lot numbers and their performance characteristics

  • Document any adjustments made to protocols based on lot variation

  • Consider including lot information in publications to aid reproducibility

• Long-term Strategy:

  • Reserve aliquots of well-characterized antibody lots for critical experiments

  • Validate new lots before depleting current working stocks

  • Consider developing in-house reference standards for long-term studies

This structured approach enables researchers to maintain experimental consistency despite inevitable lot-to-lot variations in antibody performance.